How To Win Deals In A Competitive Market, With Merck & Co. BD Exec Elizabeth Naldi-Jacob

Two Big Transactions In 2025, Potentially More In 2026

The company's deals in 2026 will range from early-stage licensing to big M&A (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from J.P. Morgan

More from Conferences